Location History:
- Huningue, FR (2013)
- Munich, DE (2015)
- Basel, CH (2023)
Company Filing History:
Years Active: 2013-2023
Title: The Innovative Contributions of Christophe Royer
Introduction
Christophe Royer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical devices, particularly in the development of injection systems. With a total of 3 patents to his name, Royer continues to push the boundaries of innovation in healthcare technology.
Latest Patents
Royer's latest patents include an injection device and an injection solution transferring system. The injection device comprises an injection solution receptacle and a plunger, with a portion of the plunger being slidably received in the receptacle. This design allows for the plunger to be displaced in a distal direction to expel the injection solution contained within. The device features a first plunger stop mechanism that halts the plunger's movement at a first dosing position, and a second mechanism that stops it at a second dosing position. This innovative approach ensures that a precise dose of the injection solution can be expelled. Additionally, he has developed a syringe specifically designed for small volume applications, such as those required for ophthalmic injections.
Career Highlights
Christophe Royer is currently employed at Novartis AG, a leading global healthcare company. His work focuses on advancing medical technologies that enhance patient care and treatment outcomes. His expertise in the field has positioned him as a key player in the development of innovative medical devices.
Collaborations
Royer has collaborated with notable colleagues, including Juergen Sigg and Andrew Mark Bryant. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Christophe Royer's contributions to the field of medical devices exemplify the spirit of innovation. His patents reflect a commitment to improving healthcare through technology. As he continues to work at Novartis AG, his future endeavors are likely to yield even more advancements in the medical field.